SCHEMBL6886965

SCHEMBL6886965

O=CC1C=CC=CC1(O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20292375 0.80
SCHEMBL5362762 0.77
SCHEMBL25399030 0.77
SCHEMBL6884828 0.75
SCHEMBL9680710 0.74
SCHEMBL28695419 0.74
SCHEMBL16797658 0.74
SCHEMBL9187292 0.74
SCHEMBL21179396 0.74
SCHEMBL9818515 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112939916-B Method for synthesizing coumarin-3-carboxylic acid compounds by one-pot two-step method 河南中烟工业有限责任公司 2022-08-19 CN disclosed
CN-113024499-A Green synthesis method of coumarin-3-carboxylic acid compounds 河南中烟工业有限责任公司 2021-06-25 CN disclosed
CN-112939916-A Method for synthesizing coumarin-3-carboxylic acid compounds by one-pot two-step method 河南中烟工业有限责任公司 2021-06-11 CN disclosed
WO-2019174533-A1 SMALL MOLECULE PD-1/PD-L1 INHIBITOR AND USE THEREOF IN DRUGS 广东东阳光药业有限公司 2019-09-19 WO disclosed
CN-103930407-B Aminopyrimidine derivatives useful as modulators of kinase activity 默克专利有限公司 2019-02-26 CN disclosed
WO-2004110351-A2 HETEROCYCLIC COMPOUNDS FOR TREATING HEPATITIS C VIRUS ANADYS PHARMACEUTICALS, INC. (US) 2004-12-23 WO disclosed